The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion
- 25 May 2010
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 53 (9) , 1935-1946
Abstract
Suppressor of cytokine signalling (SOCS) proteins are powerful inhibitors of pathways involved in survival and function of pancreatic beta cells. Whereas SOCS1 and SOCS3 have been involved in immune and inflammatory processes, respectively, in beta cells, nothing is known about SOCS2 implication in the pancreas.Keywords
This publication has 54 references indexed in Scilit:
- Chronic Palmitate Exposure Inhibits Insulin Secretion by Dissociation of Ca2+ Channels from Secretory GranulesCell Metabolism, 2009
- Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish MenDiabetes, 2009
- Growth factor control of pancreatic islet regeneration and functionPediatric Diabetes, 2009
- Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistanceProceedings of the National Academy of Sciences of the United States of America, 2007
- SOCS proteins, cytokine signalling and immune regulationNature Reviews Immunology, 2007
- A genome-wide association study identifies novel risk loci for type 2 diabetesNature, 2007
- Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivoAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the JapaneseGenomics, 2006
- Suppressor of cytokine signalling‐2 and epidermal growth factor regulate neurite outgrowth of cortical neuronsEuropean Journal of Neuroscience, 2004
- Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signalingNature Neuroscience, 2002